PLVAP and experimental autoimmune encephalomyelitis: Moreover, PV1 human homologue, FR104, was shown to be effective in preventing renal allograft rejection ([35]), and in the treatment of skin inflammation [36, 37] and experimental autoimmune encephalomyelitis [38] in non-human primates.